Medicines Co. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
687,864.00
659,690.00
309,007.00
143,161.00
44,789.00
6,138
Cost of Goods Sold (COGS) incl. D&A
267,324.00
233,330.00
116,331.00
60,653.00
47,193.00
6,655
Gross Income
420,540.00
426,360.00
192,676.00
82,508.00
2,404.00
517
SG&A Expense
380,607.00
454,466.00
441,908.00
279,527.00
273,880.00
173,179
EBIT
39,933.00
-
-
-
276,284.00
173,696
Unusual Expense
26,742.00
18,236.00
4,356.00
22,542.00
388,812.00
69,596
Non Operating Income/Expense
18,960.00
25,154.00
30,305.00
284,601.00
9,389.00
6,599
Interest Expense
15,531.00
15,701.00
37,092.00
44,463.00
48,564.00
49,411
Pretax Income
16,620.00
2,128.00
251,663.00
20,577.00
704,271.00
286,104
Income Tax
1,360.00
2,309.00
29,743.00
67.00
96,576.00
50,888
Consolidated Net Income
15,260.00
181.00
221,920.00
20,510.00
607,695.00
235,216
Net Income
15,512.00
319.00
221,930.00
20,564.00
607,695.00
235,216
Net Income After Extraordinaries
15,512.00
32,848.00
91,104.00
160,246.00
507,017.00
347,276
Net Income Available to Common
15,512.00
32,210.00
352,756.00
120,122.00
708,373.00
292,111
EPS (Basic)
0.25
0.50
5.28
1.70
9.79
1.67
Basic Shares Outstanding
58,096.00
64,473.00
66,809.00
69,909.00
72,356.00
73,571
EPS (Diluted)
0.25
0.48
5.28
1.70
9.79
1.67
Diluted Shares Outstanding
62,652.00
66,668.00
66,809.00
69,909.00
72,356.00
73,571
EBITDA
72,171.00
6,292.00
227,532.00
175,019.00
254,310.00
170,501
Minority Interest Expense
252.00
138.00
10.00
54.00
-
-
Equity in Affiliates (Pretax)
-
1,711.00
-
-
-
-
About Medicines
View Profile
